Molecular Markers Guiding Thyroid Cancer Management

Molecular Markers Guiding Thyroid Cancer Management

The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical models, high throughput molecular technologies, and gene expression microarrays have provided a deeper understandin...

Full description

Bibliographic Details
Main Authors: Carolina Nylén, Robert Mechera, Isabella Maréchal-Ross, Venessa Tsang, Angela Chou, Anthony J. Gill, Roderick J. Clifton-Bligh, Bruce G. Robinson, Mark S. Sywak, Stan B. Sidhu, Anthony R. Glover
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
Genomics
molecular testing
thyroid cancer
surgery
indeterminate nodules
tyrosine kinase inhibitors
Online Access:https://www.mdpi.com/2072-6694/12/8/2164

Similar Items

Similar Items